| Product Code: ETC11635529 | Publication Date: Apr 2025 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of cholesterol lowering agents in Brunei continued to be dominated by key exporters such as Malaysia, Singapore, Ireland, USA, and Australia in 2024. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), reached a very high level in 2024, indicating a high level of market concentration among these exporting countries. Despite a negative Compound Annual Growth Rate (CAGR) of -12.13% from 2020 to 2024, the market showed a slight improvement with a lower decline in growth rate of -5.61% from 2023 to 2024. This suggests a stabilization in the market for cholesterol lowering agents in Brunei.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei Cholesterol Lowering Agents Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei Cholesterol Lowering Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Brunei Cholesterol Lowering Agents Market - Industry Life Cycle |
3.4 Brunei Cholesterol Lowering Agents Market - Porter's Five Forces |
3.5 Brunei Cholesterol Lowering Agents Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Brunei Cholesterol Lowering Agents Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Brunei Cholesterol Lowering Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Brunei Cholesterol Lowering Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Brunei Cholesterol Lowering Agents Market Trends |
6 Brunei Cholesterol Lowering Agents Market, By Types |
6.1 Brunei Cholesterol Lowering Agents Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Brunei Cholesterol Lowering Agents Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Brunei Cholesterol Lowering Agents Market Revenues & Volume, By Statins, 2021 - 2031F |
6.1.4 Brunei Cholesterol Lowering Agents Market Revenues & Volume, By Bile Acid Sequestrants, 2021 - 2031F |
6.1.5 Brunei Cholesterol Lowering Agents Market Revenues & Volume, By Nicotinic Acid, 2021 - 2031F |
6.1.6 Brunei Cholesterol Lowering Agents Market Revenues & Volume, By PCSK9 Inhibitors, 2021 - 2031F |
6.1.7 Brunei Cholesterol Lowering Agents Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Brunei Cholesterol Lowering Agents Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Brunei Cholesterol Lowering Agents Market Revenues & Volume, By Hypercholesterolemia, 2021 - 2031F |
6.2.3 Brunei Cholesterol Lowering Agents Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.2.4 Brunei Cholesterol Lowering Agents Market Revenues & Volume, By Hyperlipidemia, 2021 - 2031F |
6.3 Brunei Cholesterol Lowering Agents Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Brunei Cholesterol Lowering Agents Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 Brunei Cholesterol Lowering Agents Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Brunei Cholesterol Lowering Agents Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Brunei Cholesterol Lowering Agents Market Import-Export Trade Statistics |
7.1 Brunei Cholesterol Lowering Agents Market Export to Major Countries |
7.2 Brunei Cholesterol Lowering Agents Market Imports from Major Countries |
8 Brunei Cholesterol Lowering Agents Market Key Performance Indicators |
9 Brunei Cholesterol Lowering Agents Market - Opportunity Assessment |
9.1 Brunei Cholesterol Lowering Agents Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Brunei Cholesterol Lowering Agents Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Brunei Cholesterol Lowering Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Brunei Cholesterol Lowering Agents Market - Competitive Landscape |
10.1 Brunei Cholesterol Lowering Agents Market Revenue Share, By Companies, 2024 |
10.2 Brunei Cholesterol Lowering Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here